148-149 / 328
EXPERT REVIEW PANEL MEMBERS
OBSERVERS
Name
Organization
Name
Organization
Michael Brodsky, Chair
Brodsky Consultants
Patrick Bird
Q Laboratories
Yi Chen
US FDA-CFSAN
Ronald Johnson
bioMérieux, Inc.
Maria C. Fernandez
ANMAT/Ministry of Health Univ. of Buenos
Aires
John Mills
bioMérieux, Inc.
Tony Hitchins
US FDA-CFSAN (retired)
Ray Turnley
bioMérieux, Inc.
Yvonne Salfinger
Not Present
Wendy McMahon
Silliker, Inc.
Maya Achen
Ohio Dept. of Agriculture
Below are the recommendations from the voting members of the ERP based
upon their submitted method review forms for the ERP adopt this method as
an AOAC
Official Method of Analysis (First Action status)
.
Donna Douey
CFIA
Dermot Hayes
Chair, Committee on Safety
Robert LaBudde
Member, Committee on Statistics
Recommendation
Thomas Hammack
US FDA-CFSAN
Reviewer
OMAMAN-02
OMAMAN-03
Michael Brodsky, Chair
First Action
First Action w/editorial
changes
AOAC STAFF
Yi Chen
First Action
First Action w/data
Jim Bradford, Executive Director
Donna Douey
First Action, if
concerns are
addressed by ERP
First Action, if
concerns are
addressed by ERP
Deborah McKenzie
Tony Hitchins
First Action
First Action
Tien Milor
Maya Achen
First Action
First Action
La’Kia Phillips
Maria C. Fernandez
First Action
First Action
Yvonne Salfinger
First Action w/minor
changes
First Action w/changes
ERP PROFILE SUMMARIES
120